Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

Charity hails ‘momentous’ decision to give abiraterone to about 8,000 newly diagnosed men each year ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has accepted the filing ...

CHICAGO -- There is more evidence that taking vitamin E pills can be risky. A study that followed up on men who took high doses of the vitamin for about five years found they had a slightly increased ...

England will join Scotland and Wales in widening access to the prostate cancer drug abiraterone, following a public campaign.